Scandinavian CRO

Bengt holds a Master of Science in Pharmacy, a PhD in the Medical Sciences from Uppsala University, as well as a Diploma in Pharmaceutical Medicine from the Swiss Association of Pharmaceutical Professionals and EUCOR universities. With more than 25 years of experience in the pharma industry, Bengt has held positions such as Nordic Medical Director at Novartis and Celgene and Nordic Clinical Research Director at Sanofi-Aventis. Bengt is currently Head of Global Medical Affairs at Oncopeptides AB, Board Director at Nanexa AB, and Owner/CEO of Sangus Jazz AB. Bengt has been involved in the launch of more than 10 different approved drugs and has worked in all phases of clinical studies.

Mattias has a Bachelor of Science in Business and Marketing and has studied at the University of Dalecarlia, University of Borås, and Stockholm University. Mattias has more than 23 years of experience in the pharma and biotech industry. His previous experience includes roles as Nordic Marketing Director of Oncology at AstraZeneca and Global Brand Manager at AstraZeneca UK for different oncology drugs. Since 2012, Mattias has worked as Clinical Development Director at Biovica International AB as well as being active as a strategic consultant within pharma, medtech and biotech. Mattias has also been active in several clinical study collaborations including as a co-investigator in a Southwest Oncology Group trial (SWOG-trial).